Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study

Journal of Periodontology

Volumn 72, Issue 5, 2001, Pages 651-658

  Hunt, Dennis R ^a   Jovanovic, Sascha A ^a,d   Wikesjö, Ulf M E ^b   Wozney, John M ^c   Bernard, George W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c PFIZER INC   (United States)

^d UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Alveolar ridge augmentation; Animal studies; Bone regeneration; Collagen therapeutic use; Hyaluronan therapeutic use; Protein, bone morphogenetic; Protein, recombinant

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CARRIER PROTEIN; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CONDUCTION; BONE MATRIX; BONE REMODELING; CONTROLLED STUDY; DOG; HISTOLOGY; HISTOMETRY; IMPLANTATION; NONHUMAN; PROSTHESIS;

ABSORBABLE IMPLANTS; ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ALVEOLAR RIDGE AUGMENTATION; ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE SUBSTITUTES; COLLAGEN; DOGS; DRUG CARRIERS; HUMANS; HYALURONIC ACID; OSTEOGENESIS; PILOT PROJECTS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035018439     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.5.651     Document Type: Article

References (40)

1. Buser D, Dula K, Hess D, Hirt HP, Belser UC. Localized ridge augmentation with autografts and barrier membranes. Periodontol 2000 1999;19:151-163.
2. Simion M, Jovanovic SA, Trisi P, Scarano A, Piattelli A. Vertical ridge augmentation around dental implants using a membrane technique and autogenous bone or allografts in humans. Int J Periodontics Restorative Dent 1998;18:8-23.
3. Lekholm U, Becker W, Dahlin C, Becker BE, Donath K, Morrison E. The role of early versus late removal of GTAM membranes on bone formation at oral implants placed into immediate extraction sockets. An experimental study in dogs. Clin Oral Implants Res 1993;4:121-129.
4. Cho K-S, Choi S-H, Han K-H, Chai J-K, Wikesjö UME, Kim C-K. Alveolar bone formation at dental implant dehiscence defects following guided bone regeneration and xenogeneic freeze dried demineralized bone matrix. Clin Oral Implants Res 1998;9:419-428.
5. Jovanovic SA, Bernard G, Spiekermann H, Hunt D. rhBMP-2 grafting in critical size mandibular defects with barrier membranes. J Dent Res 1996;75(Spec. Issue): 31(Abstr. 111).
6. Jovanovic SA, Nevins M. Bone formation utilizing titanium-reinforced barrier membranes. Int J Periodontics Restorative Dent 1995;15:56-69.
7. Simion M, Trisi P, Piattelli A. Vertical ridge augmentation using a membrane technique associated with osseointegrated implants. Int J Periodontics Restorative Dent 1994;14:496-511.
8. Jovanovic SA, Schenk RK, Orsini M, Kenney EB. Supracrestal bone formation around dental implants: An experimental dog study. Int J Oral Maxillofac Implants 1995;10:23-31.
9. Caplanis N, Sigurdsson TJ, Rohrer MD, Wikesjö UME. Effect of allogeneic, freeze-dried, demineralized bone matrix on guided bone regeneration in supra-alveolar peri-implant defects in dogs. Int J Oral Maxillofac Implants 1997;12:634-642.
10. Urist MR. Bone: Formation by autoinduction. Science 1965;150:893-899.
11. Urist MR, Lietze A, Mizutani H, et al. A bovine low molecular weight bone morphogenetic protein (BMP) fraction. Clin Orthop 1982;162:219-232.
12. Mizutani H, Urist MR. The nature of bone morphogenetic protein (BMP) fractions derived from bovine bone matrix gelatin. Clin Orthop 1982;171:213-223.
13. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci (USA) 1988;85:9484-9488.
14. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534.
15. Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-20362.
16. Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R. Recombinant Vgr-1/BMP-6 expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994;126:1595-1609.
17. Boyne PJ. Animal studies of the application of rhBMP-2 in maxillofacial reconstruction. Bone 1996;19:83S-92S.
18. Boyne PJ, Nath R, Nakamura A. Human recombinant BMP-2 in osseous reconstruction of simulated cleft palate defects. Br J Oral Maxillofac Surg 1998;36:84-90.
19. Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UME. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 1997;12: 604-610.
20. Hanisch O, Tatakis DN, Rohrer MD, Wöhrle PS, Wozney JM, Wikesjö UME. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 1997;12:785-792.
21. Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjö UME. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8:367-374.
22. Barboza EP, Leite Duarte ME, Geolás L, Sorensen RG, Riedel GE, Wikesjö UME. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000;71:488-496.
23. Laurent TC. The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives. Wenner-Gren International Series, vol. 72, London: Portland Press; 1998.
24. Toole BP. Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Hay E, ed. Cell Biology of Extracellular Matrix, 2nd ed. New York: Plenum Press; 1991:305-341.
25. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228:1324-1326.
26. Roy F, DeBlois C, Doillon CJ. Extracellular matrix analogs as carriers for growth factors: In vitro fibroblast behavior. J Biomed Mater Res 1993;27:389-397.
27. Yerushalmi N, Arad A, Margalit R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. Arch Biochem Biophys 1994;313:267-273.
28. Radomsky ML, Thompson AY, Spiro RC, Poser JW. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop 1998;355(Suppl.):S283-S293.
29. Solchaga LA, Dennis JE, Goldberg VM, Caplan AI. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J Orthop Res 1999;17:205-213.
30. Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. Biomed Mater Res 1999;47:152-169.
31. Pirnazar P, Wolinsky L, Nachnani S, Haake S, Pilloni A, Bernard GW. Bacteriostatic effects of hyaluronic acid. J Periodontol 1999;70:370-374.
32. Schenk RK, Buser D, Hardwick WR, Dahlin C. Healing pattern of bone regeneration in membrane-protected defects: A histologic study in the canine mandible. Int J Oral Maxillofac Implants 1994;9:13-29.
33. Donath K, Breuner G. A method for the study of undecalcified bone and teeth with attached soft tissues. The Saege-Schiff technique. Oral Pathol 1982;11:318.
34. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjö UME. Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995;66:131-138.
35. Sigurdsson TJ, Nguyen-Su S, Wikesjö UME. rhBMP-2 induced supraalveolar ridge augmentation and dental implant osseointegration in dogs. Int J Periodontics Restorative Dent 2001; in press.
36. Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunol 1980;40: 435-446.
37. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6: 2397-2404.
38. Fisher M, Solursh M. Glycosaminoglycan localization and role in maintenance of tissue spaces in the early chick embryo. J Embryol Exp Morph 1977;42:195-207.
39. Williams DF, Campoccia D. In vitro and in vivo biocompatibility of hyaluronic acid derivatives. In: Williams DF, ed. Novel Biomaterials Based on Hyaluronic Acid and Its Derivatives. Proceedings of a Workshop Held at the Annual Meeting of the European Society for Biomaterials 1994. Pisa: Fidia Advanced Biopolymers srl; 1995: 30-37.
40. Toriumi DM, O'Grady K, Horlbeck DM, Desai D, Turek TJ, Wozney J. Mandibular reconstruction using bone morphogenetic protein 2: Long-term follow-up in a canine model. Laryngoscope 1999;109:1481-1489.